A mutation in the filamin c gene causes myofibrillar myopathy with lower motor neuron syndrome: a case report.


Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
17 Aug 2019
Historique:
received: 28 12 2018
accepted: 23 07 2019
entrez: 19 8 2019
pubmed: 20 8 2019
medline: 26 11 2019
Statut: epublish

Résumé

Myofibrillar myopathies (MFMs) are a genetically heterogeneous group of muscle disorders. Mutations in the filamin C gene (FLNC) have previously been identified in patients with MFM. The phenotypes of FLNC-related MFM are heterogeneous. The patient was a 37-year-old male who first experienced weakness in the distal muscles of his hand, which eventually spread to the lower limbs and proximal muscles. Serum creatine kinase levels were moderately elevated. Obvious neuropathic changes in the electromyographic exam and edema changes in lower distal limb magnetic resonance imaging were observed. Histopathological examination revealed the presence of abnormal protein aggregates and angular atrophy in some muscle fibers. Ultrastructural analysis showed inordinate myofibrillar structures and dissolved myofilaments. DNA sequencing analysis detected a heterozygous missense mutation (c.7123G > A, p.V2375I) in the immunoglobulin (Ig)-like domain 21 of FLNC. FLNC mutation c.7123G > A, p.V2375I in the immunoglobulin (Ig)-like domain 21 can be associated with distal myopathy with typical MFM features and lower motor neuron syndrome. Although electromyographic examination of our patient showed obvious neuropathic changes, MFM could not be excluded. Therefore, genetic testing is necessary to make an accurate diagnosis.

Sections du résumé

BACKGROUND BACKGROUND
Myofibrillar myopathies (MFMs) are a genetically heterogeneous group of muscle disorders. Mutations in the filamin C gene (FLNC) have previously been identified in patients with MFM. The phenotypes of FLNC-related MFM are heterogeneous.
CASE PRESENTATION METHODS
The patient was a 37-year-old male who first experienced weakness in the distal muscles of his hand, which eventually spread to the lower limbs and proximal muscles. Serum creatine kinase levels were moderately elevated. Obvious neuropathic changes in the electromyographic exam and edema changes in lower distal limb magnetic resonance imaging were observed. Histopathological examination revealed the presence of abnormal protein aggregates and angular atrophy in some muscle fibers. Ultrastructural analysis showed inordinate myofibrillar structures and dissolved myofilaments. DNA sequencing analysis detected a heterozygous missense mutation (c.7123G > A, p.V2375I) in the immunoglobulin (Ig)-like domain 21 of FLNC.
CONCLUSIONS CONCLUSIONS
FLNC mutation c.7123G > A, p.V2375I in the immunoglobulin (Ig)-like domain 21 can be associated with distal myopathy with typical MFM features and lower motor neuron syndrome. Although electromyographic examination of our patient showed obvious neuropathic changes, MFM could not be excluded. Therefore, genetic testing is necessary to make an accurate diagnosis.

Identifiants

pubmed: 31421687
doi: 10.1186/s12883-019-1410-7
pii: 10.1186/s12883-019-1410-7
pmc: PMC6697925
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

198

Subventions

Organisme : Shenzhen Science and Technology Innovation Commission
ID : JCY-0150605103420338

Références

Brain. 2004 Feb;127(Pt 2):439-51
pubmed: 14711882
Brain. 2007 Dec;130(Pt 12):3250-64
pubmed: 18055494
Am J Hum Genet. 2011 Jun 10;88(6):729-740
pubmed: 21620354
Neurology. 2011 Dec 13;77(24):2105-14
pubmed: 22131542
Muscle Nerve. 2012 Aug;46(2):275-82
pubmed: 22806379
Brain. 2012 Sep;135(Pt 9):2642-60
pubmed: 22961544
Handb Clin Neurol. 2013;113:1337-42
pubmed: 23622358
Curr Opin Neurol. 2013 Oct;26(5):527-35
pubmed: 23995273
Rev Neurol (Paris). 2016 Oct;172(10):594-606
pubmed: 27633507
Neuromuscul Disord. 2017 Jan;27(1):73-77
pubmed: 27816332
J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):474-483
pubmed: 28003344
Rev Neurol (Paris). 2017 May;173(5):320-325
pubmed: 28434507
PLoS One. 2017 Oct 26;12(10):e0186642
pubmed: 29073160
BMC Neurol. 2018 Jun 4;18(1):79
pubmed: 29866061
JACC Clin Electrophysiol. 2018 Apr;4(4):504-514
pubmed: 30067491
Hum Pathol. 1995 Sep;26(9):1032-7
pubmed: 7672786
J Neuropathol Exp Neurol. 1996 May;55(5):563-77
pubmed: 8627347

Auteurs

Juanjuan Chen (J)

Department of Neurology, Peking University Shenzhen Hospital, Lianhua Road 1120, Futian District, Shenzhen, 518036, China.

Jun Wu (J)

Department of Neurology, Peking University Shenzhen Hospital, Lianhua Road 1120, Futian District, Shenzhen, 518036, China. wujun188@163.com.

Chunxi Han (C)

Department of Neurology, Shenzhen Children's Hospital, Shenzhen, China.

Yao Li (Y)

Department of Neurology, Peking University Shenzhen Hospital, Lianhua Road 1120, Futian District, Shenzhen, 518036, China.

Yuzu Guo (Y)

Department of Neurology, Peking University Shenzhen Hospital, Lianhua Road 1120, Futian District, Shenzhen, 518036, China.

Xiaoxin Tong (X)

Department of Neurology, Peking University Shenzhen Hospital, Lianhua Road 1120, Futian District, Shenzhen, 518036, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH